169 related articles for article (PubMed ID: 20675163)
1. Enzymatic activity of methionine adenosyltransferase variants identified in patients with persistent hypermethioninemia.
Fernández-Irigoyen J; Santamaría E; Chien YH; Hwu WL; Korman SH; Faghfoury H; Schulze A; Hoganson GE; Stabler SP; Allen RH; Wagner C; Mudd SH; Corrales FJ
Mol Genet Metab; 2010; 101(2-3):172-7. PubMed ID: 20675163
[TBL] [Abstract][Full Text] [Related]
2. Biochemical basis for the dominant inheritance of hypermethioninemia associated with the R264H mutation of the MAT1A gene. A monomeric methionine adenosyltransferase with tripolyphosphatase activity.
Pérez Mato I; Sanchez del Pino MM; Chamberlin ME; Mudd SH; Mato JM; Corrales FJ
J Biol Chem; 2001 Apr; 276(17):13803-9. PubMed ID: 11278456
[TBL] [Abstract][Full Text] [Related]
3. Methionine adenosyltransferase I/III deficiency: neurological manifestations and relevance of S-adenosylmethionine.
Furujo M; Kinoshita M; Nagao M; Kubo T
Mol Genet Metab; 2012 Nov; 107(3):253-6. PubMed ID: 22951388
[TBL] [Abstract][Full Text] [Related]
4. Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening.
Couce ML; Bóveda MD; García-Jimémez C; Balmaseda E; Vives I; Castiñeiras DE; Fernández-Marmiesse A; Fraga JM; Mudd SH; Corrales FJ
Mol Genet Metab; 2013 Nov; 110(3):218-21. PubMed ID: 23993429
[TBL] [Abstract][Full Text] [Related]
5. Hypermethioninemias of genetic and non-genetic origin: A review.
Mudd SH
Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):3-32. PubMed ID: 21308989
[TBL] [Abstract][Full Text] [Related]
6. Dominant inheritance of isolated hypermethioninemia is associated with a mutation in the human methionine adenosyltransferase 1A gene.
Chamberlin ME; Ubagai T; Mudd SH; Levy HL; Chou JY
Am J Hum Genet; 1997 Mar; 60(3):540-6. PubMed ID: 9042912
[TBL] [Abstract][Full Text] [Related]
7. Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency.
Chamberlin ME; Ubagai T; Mudd SH; Wilson WG; Leonard JV; Chou JY
J Clin Invest; 1996 Aug; 98(4):1021-7. PubMed ID: 8770875
[TBL] [Abstract][Full Text] [Related]
8. Mudd's disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes.
Chien YH; Abdenur JE; Baronio F; Bannick AA; Corrales F; Couce M; Donner MG; Ficicioglu C; Freehauf C; Frithiof D; Gotway G; Hirabayashi K; Hofstede F; Hoganson G; Hwu WL; James P; Kim S; Korman SH; Lachmann R; Levy H; Lindner M; Lykopoulou L; Mayatepek E; Muntau A; Okano Y; Raymond K; Rubio-Gozalbo E; Scholl-Bürgi S; Schulze A; Singh R; Stabler S; Stuy M; Thomas J; Wagner C; Wilson WG; Wortmann S; Yamamoto S; Pao M; Blom HJ
Orphanet J Rare Dis; 2015 Aug; 10():99. PubMed ID: 26289392
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of mutations associated with methionine adenosyltransferase I/III deficiency among individuals identified during newborn screening in Japan.
Nagao M; Tanaka T; Furujo M
Mol Genet Metab; 2013 Dec; 110(4):460-4. PubMed ID: 24231718
[TBL] [Abstract][Full Text] [Related]
10. S-adenosylmethionine treatment in methionine adenosyltransferase deficiency, a case report.
Furujo M; Kinoshita M; Nagao M; Kubo T
Mol Genet Metab; 2012 Mar; 105(3):516-8. PubMed ID: 22178350
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site.
González B; Pajares MA; Hermoso JA; Alvarez L; Garrido F; Sufrin JR; Sanz-Aparicio J
J Mol Biol; 2000 Jul; 300(2):363-75. PubMed ID: 10873471
[TBL] [Abstract][Full Text] [Related]
12. Neurologically normal development of a patient with severe methionine adenosyltransferase I/III deficiency after continuing dietary methionine restriction.
Hirabayashi K; Shiohara M; Yamada K; Sueki A; Ide Y; Takeuchi K; Hagimoto R; Kinoshita T; Yabuhara A; Mudd SH; Koike K
Gene; 2013 Nov; 530(1):104-8. PubMed ID: 23973726
[TBL] [Abstract][Full Text] [Related]
13. Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations.
Chamberlin ME; Ubagai T; Mudd SH; Thomas J; Pao VY; Nguyen TK; Levy HL; Greene C; Freehauf C; Chou JY
Am J Hum Genet; 2000 Feb; 66(2):347-55. PubMed ID: 10677294
[TBL] [Abstract][Full Text] [Related]
14. Isolated hypermethioninemia: measurements of S-adenosylmethionine and choline.
Mudd SH; Jenden DJ; Capdevila A; Roch M; Levy HL; Wagner C
Metabolism; 2000 Dec; 49(12):1542-7. PubMed ID: 11145114
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of hypermethioninemia in neonatal screening.
Chien YH; Chiang SC; Huang A; Hwu WL
Early Hum Dev; 2005 Jun; 81(6):529-33. PubMed ID: 15935930
[TBL] [Abstract][Full Text] [Related]
16. Methionine adenosyltransferase I/III deficiency: two Korean compound heterozygous siblings with a novel mutation.
Kim SZ; Santamaria E; Jeong TE; Levy HL; Mato JM; Corrales FJ; Mudd SH
J Inherit Metab Dis; 2002 Dec; 25(8):661-71. PubMed ID: 12705496
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat.
Huang ZZ; Mato JM; Kanel G; Lu SC
Hepatology; 1999 May; 29(5):1471-8. PubMed ID: 10216131
[TBL] [Abstract][Full Text] [Related]
18. Methionine adenosyltransferases in liver cancer.
Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
[TBL] [Abstract][Full Text] [Related]
19. The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
Pérez C; Pérez-Zúñiga FJ; Garrido F; Reytor E; Portillo F; Pajares MA
PLoS One; 2016; 11(8):e0161672. PubMed ID: 27548429
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
